Efficacy of simvastatin in major depressive disorder: A meta-analysis of randomized controlled trials
- 5 November 2025
- journal article
- review article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 97, 241-243
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and ObesityJAMA Psychiatry, 2025
- The pharmacological bases for repurposing statins in depression: a review of mechanistic studiesTranslational Psychiatry, 2023
- Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant DepressionJAMA Network Open, 2023
- Major Depression and Its Recurrences: Life Course MattersAnnual Review of Clinical Psychology, 2022
- Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trialsPLOS ONE, 2021
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2015
- Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trialJournal of Psychopharmacology, 2015
- Cross-national epidemiology of DSM-IV major depressive episodeBMC Medicine, 2011